Serum β-Defensin-2 Levels and Their Relationship with the Clinical Course and Prognosis in Patients with Crimean-Congo Hemorrhagic Fever
- PMID: 26539993
- PMCID: PMC5588343
- DOI: 10.1159/000442177
Serum β-Defensin-2 Levels and Their Relationship with the Clinical Course and Prognosis in Patients with Crimean-Congo Hemorrhagic Fever
Abstract
Objective: The aim of this study was to investigate the role of the clinical course and prognosis of serum levels of β-defensin-2 (BD-2) in patients with Crimean-Congo hemorrhagic fever (CCHF).
Subjects and methods: Patients who were hospitalized in the Department of Infectious Diseases and Clinical Microbiology of the Faculty of Medicine, Ataturk University, were considered for inclusion in this study. The patients had positive real-time reverse transcription polymerase chain reaction and/or enzyme-linked immunosorbent assay results of the CCHF virus. There were 60 patients with CCHF in the study group and 25 healthy participants in the control group. Serum BD-2 levels were measured using ELISA. Data were analyzed using the Student t test or Mann-Whitney U test.
Results: Of the 60 patients, 6 (10%) died and 54 (90%) were discharged following their recovery. The mean BD-2 level of the patient group was significantly higher (4,180.30 ± 3,944.19 pg/ml) than that of the control group (964.45 ± 266.07 pg/ml; p = 0.001). Serum BD-2 levels of the patients with fatal (1,529.81 ± 1,028.14) and nonfatal disease (4,474.80 ± 4,041.58) differed, but this difference showed only borderline significance (p = 0.055). The mean BD-2 level of the severe group was 5,507.45 ± 4,327.06 pg/ml, while it was 3,611.52 ± 3,676.73 pg/ml in the mild/moderate group, and both were significantly higher than that of the control group (p = 0.001).
Conclusion: In this study, the expression of serum BD-2 was raised in patients with CCHF, and this increase may beneficially affect survival. Studies with larger sample sizes are needed to confirm the association of serum BD-2 with CCHF prognosis.
© 2015 S. Karger AG, Basel.
Similar articles
-
Mean platelet volume in the diagnosis and prognosis of Crimean-Congo hemorrhagic fever.Clin Appl Thromb Hemost. 2013 Jul-Aug;19(4):441-4. doi: 10.1177/1076029612440035. Epub 2012 Mar 19. Clin Appl Thromb Hemost. 2013. PMID: 22431857
-
Serum levels of Mannan-binding lectin in patients with Crimean-Congo hemorrhagic fever.Vector Borne Zoonotic Dis. 2010 Dec;10(10):1037-41. doi: 10.1089/vbz.2009.0060. Epub 2010 Apr 28. Vector Borne Zoonotic Dis. 2010. PMID: 20426687
-
Presepsin Levels of Patients with Crimean-Congo Hemorrhagic Fever.Jpn J Infect Dis. 2016 Nov 22;69(6):505-509. doi: 10.7883/yoken.JJID.2015.392. Epub 2016 Mar 18. Jpn J Infect Dis. 2016. PMID: 27000451
-
Diagnosis of Crimean-Congo hemorrhagic fever.Expert Rev Anti Infect Ther. 2015 May;13(5):555-66. doi: 10.1586/14787210.2015.1021782. Epub 2015 Mar 6. Expert Rev Anti Infect Ther. 2015. PMID: 25746112 Review.
-
Crimean Congo hemorrhagic fever: requires vigilance and not panic.J Assoc Physicians India. 2011 Mar;59:164-7. J Assoc Physicians India. 2011. PMID: 21751625 Review.
Cited by
-
Nosocomial Valve Endocarditis after Crimean-Congo Hemorrhagic Fever.Rev Soc Bras Med Trop. 2022 Jun 6;55:e0691. doi: 10.1590/0037-8682-0691-2021. eCollection 2022. Rev Soc Bras Med Trop. 2022. PMID: 35674564 Free PMC article. No abstract available.
-
Antiviral and Immunomodulatory Properties of Antimicrobial Peptides Produced by Human Keratinocytes.Front Microbiol. 2020 Jun 3;11:1155. doi: 10.3389/fmicb.2020.01155. eCollection 2020. Front Microbiol. 2020. PMID: 32582097 Free PMC article. Review.
-
Antiviral Activities of Human Host Defense Peptides.Curr Med Chem. 2020;27(9):1420-1443. doi: 10.2174/0929867326666190805151654. Curr Med Chem. 2020. PMID: 31385762 Free PMC article. Review.
References
-
- Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145–160. - PubMed
-
- Akıncı E, Bodur H, Leblebicioglu H. Pathogenesis of Crimean-Congo hemorrhagic fever. Vector Borne Zoonotic Dis. 2013;13:429–437. - PubMed
-
- Guaní-Guerra E, Santos-Mendoza T, Lugo-Reyes SO, et al. Antimicrobial peptides: general overview and clinical implications in human health and disease. Clin Immunol. 2010;135:1–11. - PubMed
-
- Swanepoel R, Gill DE, Shepherd AJ, et al. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev Infect Dis. 1989;11:794–800. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical